Skip to content

comparison of the effect of PRP versus corticosteroid injection in treatment of tennis elbow

Studing of the effect of platelet rich plasma versus corticosteroid injection on pain and function of patients with lateral epicondylitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130523013442N16
Enrollment
44
Registered
2017-11-28
Start date
2017-08-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis. Lateral epicondylitis

Interventions

Intervention 1: Control group:. 8 minutes after being prepped and draped and injected by 2cc of Lidocaine 1%, the point of maximum tenderness will be injected by 40mg of methylprednisolone acetate wit
Treatment - Drugs
Control group:. 8 minutes after being prepped and draped and injected by 2cc of Lidocaine 1%, the point of maximum tenderness will be injected by 40mg of methylprednisolone acetate with a volume of 1
Intervention group: 8 minutes after being prepped and draped and injected by 2cc of Lidocaine 1%, the point of maximum tenderness will be injected by 2cc of leukocyte rich PRP with peppering technique

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 70 Years

Inclusion criteria

Inclusion criteria: Patients with lateral epicondylitis and related functional impairments diagnosed by resisted wrist extension test in forearm pronation and elbow extension VAS score=5 or more symptoms lasting for at least 3 months

Exclusion criteria

Exclusion criteria: Age of 70 years old or more History of infectious diseases or fever in recent days History of any malignancies Diagnosed carpal tunnel syndrome or any other peripheral nerve lesions or cervical radiculopathy Systemic diseases such as ischemic heart disease, diabetes mellitus, rheumatoid arthritis or hepatitis Any bone malformations or bone injuries in humerus or elbow joint History of autoimmune diseases History of Platelet dysfunction, using anti platelet medications during last 10 days or using NSAIDs during last 48 hours before injection Using steroids during last 3 weeks Hb=10 or less patients with platelet count less than 150000 History of vasovagal reaction Pregnency or breast feeding

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: before injection, 2 and 6 months after injection. Method of measurement: VAS score, Pain pressure threshold.;Function. Timepoint: before injection, 2 and 6 months after injection. Method of measurement: Persian version of modified Myo clinic performane index for elbow.

Secondary

MeasureTime frame
Complications of treatment. Timepoint: before injection, 2 and 6 months after injection. Method of measurement: clinical evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hesam Abdollahzadeh

Shahid Beheshti University of Medical Sciences

Hesam.Abdollahzadeh@sbmu.ac.ir+98 21 2272 4210

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026